Specification builder · Tier D+
Gas chromatograph-mass spectrometer (single-quadrupole GC-MS, EI source) with headspace and liquid autosampler options
A GC-MS separates volatile and semi-volatile compounds on a capillary GC column and identifies each one from its electron-ionisation mass spectrum, matched against spectral libraries. In Pakistan it is bought by pharma QC labs for residual-solvent identification and volatile nitrosamine testing, by drug testing and forensic labs for identifying unknown drugs and adulterants, and by food, environmental and university labs for pesticide, contaminant and natural-product work.
What this equipment will do
- Samples: solutions, extracts and solvents of drugs, foods, water, soil and natural products, injected as liquids. (with the optional module)
- Samples: solids and liquids in sealed headspace vials, where only the vapour above the sample is injected. (with the optional module)
- Samples: volatiles collected on an SPME fibre, by the robotic multi-mode sampler. (with the optional module)
- Identification of each separated compound from its electron-ionisation (70 eV) mass spectrum over 2-1000 u, in full-scan and selected-ion (SIM) modes, with quantitation (USP <736>, Ph. Eur. 2.2.43).
- Library identification of unknowns against the current NIST EI mass spectral library with retention-index data. (with the optional module)
- Seized drugs, adulterants and new psychoactive substances identified against a forensic drug library (SWGDRUG Category A technique). (with the optional module)
- Residual solvents: identification and confirmation of solvent peaks found by headspace GC (USP <467>). (with the optional module)
- Small volatile nitrosamines (NDMA, NDEA, NEIPA, NDIPA, NDBA) in drug substances and products by SIM (USP <1469>, ICH M7).
- Separation of overlapping peaks by spectral deconvolution, with automated reporting of identified compounds. (with the optional module)
- Chemical ionisation (positive and negative) to confirm molecular weight and to measure electron-capturing compounds. (with the optional module)
- FID and MS signals from the same injection, using a column flow splitter. (with the optional module)
- Data integrity for GMP labs: user log-in, audit trail and electronic signatures (21 CFR Part 11, EU GMP Annex 11). (with the optional module)
Not covered: Non-volatile, heat-sensitive or large molecules (most drug assays, related substances and drug-related nitrosamines) need HPLC or LC-MS/MS.; Confirmation at ultra-trace levels by MS/MS or accurate mass needs a triple-quadrupole or high-resolution GC-MS; this is a single-quadrupole system.; Routine USP <467> residual-solvent release testing is normally run on a headspace GC-FID; the GC-MS identifies and confirms the peaks.; Heavy metals and elemental impurities need ICP-MS/OES or an atomic absorption spectrometer.
Loading the builder...
Standards this specification draws on
- USP <736> Pharmacopoeial mass spectrometry chapter covering EI and CI ionisation, mass calibration and the instrument terms used in specifications and OQ.
- Ph. Eur. 2.2.43 European/BP mass spectrometry chapter, cited by BP-based monographs used in Pakistan.
- USP <621> Defines chromatography terms, system suitability and allowed method adjustments that the data system must support.
- USP <467> Pharmacopoeial residual-solvent procedures; GC-MS is used to identify solvents and confirm peaks found by headspace GC.
- USP <1469> Pharmacopoeial chapter on nitrosamine impurities, including GC-MS procedures and limits for small volatile nitrosamines.
- ICH M7(R2) Sets the acceptable-intake approach for mutagenic impurities such as nitrosamines, which decides how low the GC-MS method must measure.
- USP <1058> Analytical instrument qualification framework (DQ/IQ/OQ/PQ) used to accept the GC-MS and sampler.
- 21 CFR Part 11 US FDA rule on electronic records and signatures; data-system audit trails and e-signatures are checked against it.
- EU GMP Annex 11 EU/PIC/S GMP rule for computerised systems; applies to the GC-MS data system in GMP labs.
- ISO/IEC 17025:2017 Accreditation standard for testing labs; requires qualified, calibrated equipment and controlled data.
- SWGDRUG Recommendations (Version 8.2) International minimum standards for seized-drug analysis; GC-MS is a Category A identification technique used with library search.
- IEC 61010-1 Electrical safety standard for laboratory equipment.
Common mistakes in tenders for this equipment
- Copying one maker's datasheet figures (a 1.5 fg or 2.6 fg IDL, an upper mass of 1090 or 1100 u, a 30,000 u/s scan speed, a vent-free source probe or a disposable source) so only that brand complies; state the minimum your methods need with 'not less than' or 'not more than'.
- Comparing sensitivity figures measured in different ways (RMS versus peak-to-peak noise, different OFN amounts, different numbers of replicates for IDL); fix the test in the tender and repeat it at installation before acceptance.
- Leaving the NIST library, a forensic drug library, tuning compound, spare filaments and a source cleaning kit out of the bid, so the GC-MS cannot identify anything or stops at the first filament failure.
- No online UPS or a small line-interactive UPS: every load-shedding cycle vents the vacuum, risks the turbo pump and filament, and costs a day of pump-down and re-tuning.
- Ignoring helium supply: no change-over manifold, traps or second cylinder, or specifying helium-only operation without considering a hydrogen-rated source as a fallback.
- Warranty or service contract that excludes the turbo pump, fore-pump and electron multiplier, which are the costliest parts to replace on a single-quadrupole system.
- Buying a single-quadrupole GC-MS for nitrosamine drug-substance-related impurities or very low limits in high-dose products, where GC-MS/MS or LC-MS/MS is needed.
- Asking for DRAP medical-device registration: a GC-MS is laboratory equipment, so this demand only confuses bidders.
